US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 10, 2011 (15 years ago)

Hipoglos Ointment

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Misbranded

What was recalled

Hipoglos Ointment (zinc oxide and lanolin), Helps prevent and treat diaper rash, skin irritation, Manufactured by Laboratorios Andromaco S.A. Av. Quilin 5273, Penalolen, Santiago. www.hipoglos.cl, www.laboratoriosandromaco.cl, Made in Chile, Net wt. per Tube: a) 0.18 oz (5 g), NDC: 50145-111-05; b) 2.2 oz (60 g), NDC: 50145-111-04; c) 2.5 oz (72 g), NDC: 50145-111-03; d) 3.5 oz (100 g), NDC: 50145-111-02; e) 4.2 oz (120 g), NDC: 50145-111-01.

Recalling firm
Victus, Inc.
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1652-2012

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Zinc recalls

See all
Class II · Moderate risk Ongoing

Rohto Cooling Eye Drops ALL-IN-ONE

Reason Lack of Assurance of Sterility

Rohto-Mentholatum (Vietnam) Co., Ltd. NDC 10742-8146-1 D-0715-2026
Class II · Moderate risk Ongoing

Med Pride

Reason CGMP Deviations; deficiencies observed during FDA inspection

Dabur India Limited D-0642-2026
Class II · Moderate risk Ongoing

Med Pride

Reason CGMP Deviations; deficiencies observed during FDA inspection

Dabur India Limited D-0641-2026
Class II · Moderate risk Ongoing

Med Pride

Reason CGMP Deviations; deficiencies observed during FDA inspection

Dabur India Limited D-0637-2026
Class II · Moderate risk Ongoing

Med Pride

Reason CGMP Deviations; deficiencies observed during FDA inspection

Dabur India Limited D-0636-2026